Evidence map›Paper›PMID 41937449›Full record

ArticleMovement disorders : official journal of the Movement Disorder Society2026

[

Beatrice Orso, Ignacio Roura, Pietro Mattioli, Francesco Famà, Federico Massa, Luigi Lorenzini, Andrea Brugnolo, Nicola Girtler, Mattia Losa, Stefano Raffa and 6 more

Abstract read
In one paragraph

Article in Movement disorders : official journal of the Movement Disorder Society, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Beatrice OrsoDepartment of Neuroscience, Rehabilitation, Ophthalmology, Genetics, Maternal and Child Health (DINOGMI), University of Genoa, Genoa, Italy.ORCID https://orcid.org/0000-0001-9983-7940
Ignacio RouraMedical Psychology Unit, Department of Medicine, Institute of Neurosciences, University of Barcelona, Barcelona, Spain.ORCID https://orcid.org/0000-0001-8877-899X
Pietro MattioliDepartment of Neuroscience, Rehabilitation, Ophthalmology, Genetics, Maternal and Child Health (DINOGMI), University of Genoa, Genoa, Italy.ORCID https://orcid.org/0000-0003-2563-5830
Francesco FamàDepartment of Neuroscience, Rehabilitation, Ophthalmology, Genetics, Maternal and Child Health (DINOGMI), University of Genoa, Genoa, Italy.
Federico MassaDepartment of Neuroscience, Rehabilitation, Ophthalmology, Genetics, Maternal and Child Health (DINOGMI), University of Genoa, Genoa, Italy.ORCID https://orcid.org/0000-0001-5667-204X
Luigi LorenziniDepartment of Neuroscience, Rehabilitation, Ophthalmology, Genetics, Maternal and Child Health (DINOGMI), University of Genoa, Genoa, Italy.
Andrea BrugnoloDepartment of Neuroscience, Rehabilitation, Ophthalmology, Genetics, Maternal and Child Health (DINOGMI), University of Genoa, Genoa, Italy.
Nicola GirtlerDepartment of Neuroscience, Rehabilitation, Ophthalmology, Genetics, Maternal and Child Health (DINOGMI), University of Genoa, Genoa, Italy.
Mattia LosaDepartment of Neuroscience, Rehabilitation, Ophthalmology, Genetics, Maternal and Child Health (DINOGMI), University of Genoa, Genoa, Italy.
Stefano RaffaDepartment of Health Science (DISSAL), University of Genoa, Genoa, Italy.
Luca SofiaDepartment of Health Science (DISSAL), University of Genoa, Genoa, Italy.
Monica RoascioDepartment of Informatics, Bioengineering, Robotics and System Engineering (DIBRIS), University of Genoa, Genoa, Italy.ORCID https://orcid.org/0000-0002-4522-1574
Gabriele ArnulfoDepartment of Informatics, Bioengineering, Robotics and System Engineering (DIBRIS), University of Genoa, Genoa, Italy.
Silvia MorbelliNuclear Medicine Unit, AOU Città Della Salute e Della Scienza di Torino, Turin, Italy.
Matteo PardiniDepartment of Neuroscience, Rehabilitation, Ophthalmology, Genetics, Maternal and Child Health (DINOGMI), University of Genoa, Genoa, Italy.
Dario ArnaldiDepartment of Neuroscience, Rehabilitation, Ophthalmology, Genetics, Maternal and Child Health (DINOGMI), University of Genoa, Genoa, Italy.

Funding

Ministero della Salute RF-2021-12374240Ministero dell'Istruzione, dell'Università e della Ricerca BANDO PRIN 2022 Prot. 2022WK7NHCMinistero dell'Istruzione, dell'Università e della Ricerca CUP C13C23001070006Ministero dell'Istruzione, dell'Università e della Ricerca MNESYS (PE0000006)Ministero dell'Istruzione, dell'Università e della Ricerca PNRR-MCNT2-2023-12377527
6 · The paper itself

Abstract

background[

objectivesTo assess [

methodsWe included 83 prodromal subjects with iRBD, comprising non-converters (n = 56) and converters (n = 27) to an overt α-synucleinopathy (either Parkinson's disease [PD] or dementia with Lewy bodies [DLB]) according to the last available follow-up, and 85 subjects with PD (n = 40) and DLB (n = 45). For comparison, we enrolled a group of healthy subjects (n = 41). Participants underwent brain [

resultsAll disease-related patterns effectively discriminated clinical stages, from prodromal to overt α-synucleinopathies, with comparable performance. [

conclusions[

Indexed as

BrainLewy Body DiseaseParkinson DiseasePositron-Emission TomographyREM Sleep Behavior DisorderSynucleinopathiesAgedAged, 80 and overalpha-SynucleinDisease ProgressionFemaleFluorodeoxyglucose F18HumansMaleMiddle AgedNeurodegenerative Diseasesalpha-SynucleinFluorodeoxyglucose F18Radiopharmaceuticals[18F]FDG PETdisease progressionneurodegenerationneuroimagingα‐synucleinopathy

Identifiers

PMID41937449
PMCPMC13387997

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.